MS-SMART Trial for Secondary Progressive MS Announced
The phase 2 trial will compare amiloride, ibudilast, and riluzole to placebo
The MS Society UK today announced that a new clinical trial will begin accruing patients...
Clinical Research
Editors' Pick
Editors' Pick
Editors' Pick
Transcutaneous Electrical Nerve Stimulation Shows Promise in MS
This study found that electrical nerve stimulation reduced cortical motor representation in MS
Daily transcutaneous electrical nerve stimulation may decrease cortical motor representation in patients with MS...
Clinical Research
NMDA Receptors May Modulate Severity of Multiple Sclerosis
Genetic analysis shows that NMDARs may affect MS severity via synaptic transmission and plasticity
Glutamate N-methyl-D-aspartate receptors may affect synaptic transmission and plasticity, thereby modulating...
Clinical Research
Hedysari extract improves remyelination?
Editors' Pick
Papers: 5 Jul 2013 - 12 Jul 2013
Transdermal Myelin Peptides May Be Safe, Effective in MS
A myelin peptide skin patch safely reduced active MRI lesions and clinical disease activity in relapsing-remitting MS
Transdermal application of myelin peptides may be a safe and effective therapy for patients with...
Clinical Research, Drug Development
Pages
